Found: 13
Select item for more details and to access through your institution.
Evolving approaches in advanced gallbladder cancer with complete pathological response using chemo‑immunotherapy: A case report.
- Published in:
- Oncology Letters, 2024, v. 28, n. 4, p. N.PAG, doi. 10.3892/ol.2024.14606
- By:
- Publication type:
- Article
Exploring the Horizon: Anti-Fibroblast Growth Factor Receptor Therapy in Pancreatic Cancer with Aberrant Fibroblast Growth Factor Receptor Expression—A Scoping Review.
- Published in:
- Cancers, 2024, v. 16, n. 16, p. 2912, doi. 10.3390/cancers16162912
- By:
- Publication type:
- Article
Prevalence study on potential drug–drug interaction in cancer patients in Piacenza hospital’s Onco-Haematology department.
- Published in:
- Journal of Oncology Pharmacy Practice, 2018, v. 24, n. 7, p. 490, doi. 10.1177/1078155217717324
- By:
- Publication type:
- Article
Gastric cancer with brain metastasis and the role of human epidermal growth factor 2 status.
- Published in:
- Oncology Letters, 2018, v. 15, n. 4, p. 5787, doi. 10.3892/ol.2018.8054
- By:
- Publication type:
- Article
Ultrasound guidance reduces pneumothorax rate and improves safety of thoracentesis in malignant pleural effusion: report on 445 consecutive patients with advanced cancer.
- Published in:
- World Journal of Surgical Oncology, 2014, v. 12, n. 1, p. 1, doi. 10.1186/1477-7819-12-139
- By:
- Publication type:
- Article
Effectiveness of bevacizumab in first- and second-line treatment for metastatic colorectal cancer: ITACa randomized trial.
- Published in:
- Therapeutic Advances in Medical Oncology, 2020, v. 12, p. 1, doi. 10.1177/1758835920937427
- By:
- Publication type:
- Article
Cancer Treatment Closer to the Patient Reduces Travel Burden, Time Toxicity, and Improves Patient Satisfaction, Results of 546 Consecutive Patients in a Northern Italian District.
- Published in:
- Medicina (1010660X), 2023, v. 59, n. 12, p. 2121, doi. 10.3390/medicina59122121
- By:
- Publication type:
- Article
An Anticancer Drug Unit for the whole provincial oncologic network of Piacenza: improving safety and savings.
- Published in:
- Medical Oncology, 2015, v. 32, n. 2, p. 1, doi. 10.1007/s12032-014-0457-y
- By:
- Publication type:
- Article
Targeting FGFR Pathways in Gastrointestinal Cancers: New Frontiers of Treatment.
- Published in:
- Biomedicines, 2023, v. 11, n. 10, p. 2650, doi. 10.3390/biomedicines11102650
- By:
- Publication type:
- Article
Emerging Therapeutic Targets and Future Directions in Advanced Gastric Cancer: A Comprehensive Review.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2692, doi. 10.3390/cancers16152692
- By:
- Publication type:
- Article
Impact of the COVID-19 pandemic on the oncologic activities (diagnosis, treatment, clinical trials enrollment) of a general hospital in a district with high prevalence of SARS-COV-2 in Italy.
- Published in:
- Supportive Care in Cancer, 2022, v. 30, n. 4, p. 3225, doi. 10.1007/s00520-021-06667-y
- By:
- Publication type:
- Article
FOLFIRINOX or Gemcitabine Plus Nab-paclitaxel as First Line Treatment in Pancreatic Cancer: A Real-World Comparison.
- Published in:
- Cancer Diagnosis & Prognosis, 2024, v. 4, n. 2, p. 165, doi. 10.21873/cdp.10303
- By:
- Publication type:
- Article
A real-world retrospective, observational study of first-line pembrolizumab plus chemotherapy for metastatic non-squamous non-small cell lung cancer with PD-L1 tumor proportion score < 50% (PEMBROREAL).
- Published in:
- Frontiers in Oncology, 2024, p. 1, doi. 10.3389/fonc.2024.1351995
- By:
- Publication type:
- Article